肠道微生物群重塑胰腺癌的免疫微环境:免疫治疗的新途径
Shi-Hang Zheng1, Ke-Zhu Li2, Ge Feng3
1Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, 110022, China.
Molecular cancer
|December 30, 2025
概括
肠道微生物群影响胰腺癌免疫力和治疗反应. 调节肠道微生物群为增强抗瘤免疫力和改善免疫治疗结果提供了有希望的策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 胰腺癌是一种具有高度免疫抑制性瘤微环境 (TME) 的致命恶性瘤.
- 肠道微生物群在调节抗瘤免疫力方面发挥着至关重要的作用,影响免疫细胞功能.
- 微生物群落和代谢物可以影响免疫检查点抑制剂 (ICI) 和CAR-T细胞疗法等免疫疗法的有效性.
研究的目的:
- 审查关于胰腺癌中微生物群与免疫相互作用的当前知识.
- 强调针对胰腺癌的微生物组向治疗策略.
- 探索以微生物调制为指导的精密免疫疗法的未来方向.
主要方法:
- 对肠道微生物群和胰腺癌研究的文献综述.
- 分析肠道微生物影响抗瘤免疫力的机制.
- 评估针对微生物组的干预措施和生物标志物潜力.
主要成果:
- 肠道微生物群的组成和功能显著影响TME和胰腺癌的免疫监测.
- 饮食调节,益生菌,便微生物群移植 (FMT) 和代谢物补充剂显示出潜在的治疗益处.
- 肠道微生物组分析可能作为预测治疗反应和不良事件的生物标志物.
结论:
- 肠道微生物组是胰腺癌进展和治疗疗效的关键因素.
- 准肠道微生物群为增强免疫疗法和改善患者治疗结果提供了一个有希望的途径.
- 在胰腺癌治疗中,对微生物导向精密免疫疗法的进一步研究是有必要的.
相关概念视频
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K